FDA approves generic Imitrex, Eloxatin from Sun

08/12/2009 | Reuters

Sun Pharmaceutical Industries obtained FDA clearance for its generic copies of GlaxoSmithKline's migraine drug Imitrex and Sanofi-Aventis' cancer drug Eloxatin. The Indian company said it will share a 180-day market protection for generic Eloxatin with three other drug firms.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN